Survey among experts on the future role of tau-PET in clinical practice and trials.

ABSTRACT:

Background

Recent advancements in Alzheimer's disease (AD) biomarker research and clinical trials prompt reflection on the value and consequently appropriate use of tau positron emission tomography (tau-PET) in the future.

Methods

We conducted an online survey among dementia and PET experts worldwide to investigate the anticipated future role of tau-PET in clinical practice and trials.

Results

Two hundred sixty-eight dementia experts, comprising 143 clinicians and 121 researchers, covering six continents participated. The vast majority (90%) fostered a positive attitude toward the added value of tau-PET in clinical practice, particularly for staging, diagnosing, monitoring, and prognostication in a cognitively impaired memory clinic population. Experts anticipated an

SUBMITTER: Vermeiren MR 

PROVIDER: S-EPMC11582687 | biostudies-literature | 2024 Oct-Dec

REPOSITORIES: biostudies-literature